|
MREG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.12289999999005E-05 |
| Normal-vs-Stage3 |
1.63014046705712E-12 |
| Normal-vs-Stage4 |
1.41970002420777E-09 |
| Stage1-vs-Stage2 |
3.780600E-01 |
| Stage1-vs-Stage3 |
7.863400E-01 |
| Stage1-vs-Stage4 |
4.971200E-01 |
| Stage2-vs-Stage3 |
4.865000E-01 |
| Stage2-vs-Stage4 |
7.613000E-01 |
| Stage3-vs-Stage4 |
6.881000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.235600E-04 |
| Normal-vs-Asian |
1.87879711788241E-11 |
| Caucasian-vs-AfricanAmerican |
4.378800E-01 |
| Caucasian-vs-Asian |
2.227600E-01 |
| AfricanAmerican-vs-Asian |
8.436400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
6.653400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.6242562850266E-12 |
| Normal-vs-Age(61-80Yrs) |
2.39920305844521E-11 |
| Normal-vs-Age(81-100Yrs) |
1.370400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.200600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.790300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.603700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.237400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.404100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.232010E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.017800E-01 |
| Classical-VS-Follicular |
6.5492056222638E-13 |
| Classical-VS-Other |
9.608200E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
4.98499999945778E-07 |
| Tall-VS-Other |
8.823200E-01 |
| Tall-VS-Normal |
1.83880022319727E-10 |
| Follicular-VS-Other |
1.341990E-01 |
| Follicular-VS-Normal |
4.00210000000012E-05 |
| Other-VS-Normal |
3.299700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.4645997182281E-10 |
| N0-vs-N1 |
5.489400E-01 |
|
|
